Experiment 636885

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismValeriana officinalis (VALERIANACEAE)
CitationWAGNER,J: WAGNER,ML: HENING,WA:. (1998). BEYOND BENZODIAZEPINES: ALTERNATIVE PHARMACOLOGIC AGENTS FOR THE TREATMENT OF INSOMNIA.. 32(6)
Amount utilized
Compound isolated
DiseaseIN A DOUBLE-BLIND, CROSSOVER, PALACEBO-CONTROLLED TRIAL, SUBJECTIVE MEASUREMENTS OF SLEEP LATENCY AND WAKE TIME AFTER SLEEP ONSET WERE REDUCED BY MORE THAN 50% AFTER A 900-MG DOSE, WITH SMALLER EFFECTS AFTER 450 MG. THERE WERE IMPROVEMENTS IN SLEEP WHEN MEASURED IN THE SUBJECTS' HOMES, BUT THE INVESTIGATORS FAILED TO CONFIRM THE HYPNOTIC EFFECT OF VALERIAN IN A SLEEP LABORATORY. THIS DISCREPANCEY CAN BE ATTRIBUTED TO THE YOUNGER SUBJECTS AND THE MORE STRESSFUL SLEEP ENVIRONMENT IN THE LABORATORY, WHICH CAN MIMINIZE THE MILD SEDATIVE ACTIVITY OF VALERIAN.
Dose amountVAR MG
Number5
Qualitative resultEQUIVOCAL
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractH2O EXT
GenderGIVEN TO BOTH SEXES